• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二肽基肽酶 I 的进化分析。

Evolutionary Analysis of Dipeptidyl Peptidase I.

机构信息

Department of Chemistry and Biochemistry, Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, 1000 Ljubljana, Slovenia.

出版信息

Int J Mol Sci. 2022 Feb 6;23(3):1852. doi: 10.3390/ijms23031852.

DOI:10.3390/ijms23031852
PMID:35163774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8836896/
Abstract

Human dipeptidyl peptidase I (DPPI) belongs to the family of papain-like cysteine peptidases. Its distinctive features are the unique exclusion domain which enables the eponymous activity and homotetramerization of DPPI, and its dependence on chloride ions for enzymatic activity. The oligomeric state of DPPI is unique in this family of predominantly monomeric peptidases. However, a distant DPPI ortholog from has been shown to be monomeric, indicating that the oligomeric state of DPPI varies between lineages. The aim of this work was to study the evolution of DPPI, with particular attention to the structural features that determine its characteristic enzymatic activity and preferences, and to reconstruct the evolution of its oligomerization. We analyzed fifty-seven selected sequences of DPPI and confirmed its presence in three lineages, namely, Amorphea (including animals and Amoebozoa), Alveolates and the metamonad . The amino acid residues that bind the chloride ion are highly conserved in all species, indicating that the dependence on chloride ions for activity is an evolutionarily conserved feature of DPPI. The number of N-glycosylation sites is significantly increased in animals, particularly vertebrates. Analysis of homology models and subunit contacts suggests that oligomerization is likely restricted to DPPIs in the Amorphea group.

摘要

人二肽基肽酶 I(DPPI)属于木瓜蛋白酶样半胱氨酸肽酶家族。其独特特征是独特的排除域,使 DPPI 具有独特的活性和同源四聚化,以及对氯离子依赖性的酶活性。DPPI 的寡聚状态在主要为单体的肽酶家族中是独特的。然而,来自 的远缘 DPPI 同源物已被证明是单体,表明 DPPI 的寡聚状态在不同谱系之间存在差异。本工作旨在研究 DPPI 的进化,特别关注决定其特征酶活性和偏好的结构特征,并重建其寡聚化的进化。我们分析了 57 个选定的 DPPI 序列,并证实其存在于三个谱系中,即无定形生物(包括动物和变形虫)、肺泡和原生动物 。结合氯离子的氨基酸残基在所有物种中高度保守,表明对氯离子依赖性的活性是 DPPI 的一个进化保守特征。N-糖基化位点的数量在动物中显著增加,特别是在脊椎动物中。同源模型和亚基接触的分析表明,寡聚化可能仅限于无定形生物组中的 DPPI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/80d718b1d91d/ijms-23-01852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/893563d068fc/ijms-23-01852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/bc30542bbd40/ijms-23-01852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/5e8b70de50c4/ijms-23-01852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/36b8fa58e491/ijms-23-01852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/80d718b1d91d/ijms-23-01852-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/893563d068fc/ijms-23-01852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/bc30542bbd40/ijms-23-01852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/5e8b70de50c4/ijms-23-01852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/36b8fa58e491/ijms-23-01852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acea/8836896/80d718b1d91d/ijms-23-01852-g005.jpg

相似文献

1
Evolutionary Analysis of Dipeptidyl Peptidase I.二肽基肽酶 I 的进化分析。
Int J Mol Sci. 2022 Feb 6;23(3):1852. doi: 10.3390/ijms23031852.
2
Interplay between tetrameric structure, enzymatic activity and allosteric regulation of human dipeptidyl-peptidase I.人二肽基肽酶 I 的四聚体结构、酶活性和别构调节之间的相互作用。
Arch Biochem Biophys. 2019 Oct 30;675:108121. doi: 10.1016/j.abb.2019.108121. Epub 2019 Sep 28.
3
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases.人二肽基肽酶I(组织蛋白酶C)的结构:添加到内肽酶框架上的排除结构域构成了颗粒性丝氨酸蛋白酶激活机制。
EMBO J. 2001 Dec 3;20(23):6570-82. doi: 10.1093/emboj/20.23.6570.
4
Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I.小鼠二肽基肽酶I的分子克隆、染色体定位及表达
J Biol Chem. 1997 Apr 18;272(16):10695-703. doi: 10.1074/jbc.272.16.10695.
5
Purification and characterization of dipeptidyl peptidase I from human spleen.人脾脏中二肽基肽酶I的纯化与鉴定
Arch Biochem Biophys. 1992 Jun;295(2):280-8. doi: 10.1016/0003-9861(92)90519-3.
6
Dipeptidyl-peptidase I does not functionally compensate for the loss of tripeptidyl-peptidase I in the neurodegenerative disease late-infantile neuronal ceroid lipofuscinosis.二肽基肽酶I不能在功能上补偿神经退行性疾病晚期婴儿神经元蜡样脂褐质沉积症中三肽基肽酶I的缺失。
Biochem J. 2008 Oct 15;415(2):225-32. doi: 10.1042/BJ20080411.
7
Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).二肽基肽酶I(组织蛋白酶C)抑制剂的设计与评估
Arch Biochem Biophys. 2004 Jul 15;427(2):123-34. doi: 10.1016/j.abb.2004.04.011.
8
Mast cell dipeptidyl peptidase I mediates survival from sepsis.肥大细胞二肽基肽酶I介导脓毒症的存活。
J Clin Invest. 2004 Feb;113(4):628-34. doi: 10.1172/JCI19062.
9
Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I.犬肥大细胞二肽基肽酶I的调控表达、加工及分泌
J Biol Chem. 1998 Jun 19;273(25):15514-20. doi: 10.1074/jbc.273.25.15514.
10
Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I.活性髓样和淋巴样颗粒丝氨酸蛋白酶的产生需要颗粒硫醇蛋白酶二肽基肽酶I进行加工。
J Biol Chem. 1993 Feb 5;268(4):2458-67.

本文引用的文献

1
Cathepsin C inhibition as a potential treatment strategy in cancer.组织蛋白酶 C 抑制作为癌症治疗的潜在策略。
Biochem Pharmacol. 2021 Dec;194:114803. doi: 10.1016/j.bcp.2021.114803. Epub 2021 Oct 20.
2
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
3
Update on relevant trypanosome peptidases: Validated targets and future challenges.关于相关锥虫肽酶的最新研究进展:已验证的靶标和未来的挑战。
Biochim Biophys Acta Proteins Proteom. 2021 Feb;1869(2):140577. doi: 10.1016/j.bbapap.2020.140577. Epub 2020 Nov 30.
4
Human cathepsin X/Z is a biologically active homodimer.人组织蛋白酶 X/Z 是一种具有生物活性的同源二聚体。
Biochim Biophys Acta Proteins Proteom. 2021 Feb;1869(2):140567. doi: 10.1016/j.bbapap.2020.140567. Epub 2020 Nov 20.
5
The New Tree of Eukaryotes.真核生物的新树。
Trends Ecol Evol. 2020 Jan;35(1):43-55. doi: 10.1016/j.tree.2019.08.008. Epub 2019 Oct 9.
6
Interplay between tetrameric structure, enzymatic activity and allosteric regulation of human dipeptidyl-peptidase I.人二肽基肽酶 I 的四聚体结构、酶活性和别构调节之间的相互作用。
Arch Biochem Biophys. 2019 Oct 30;675:108121. doi: 10.1016/j.abb.2019.108121. Epub 2019 Sep 28.
7
Processing and Maturation of Cathepsin C Zymogen: A Biochemical and Molecular Modeling Analysis.组织蛋白酶 C 酶原的加工与成熟:生化与分子建模分析。
Int J Mol Sci. 2019 Sep 25;20(19):4747. doi: 10.3390/ijms20194747.
8
Characterization of P. falciparum dipeptidyl aminopeptidase 3 specificity identifies differences in amino acid preferences between peptide-based substrates and covalent inhibitors.鉴定恶性疟原虫二肽基肽酶 3 的特异性特征,确定基于肽的底物和共价抑制剂之间的氨基酸偏好差异。
FEBS J. 2019 Oct;286(20):3998-4023. doi: 10.1111/febs.14953. Epub 2019 Jun 24.
9
The catalytic domain of cathepsin C (dipeptidyl-peptidase I) alone is a fully functional endoprotease.组织蛋白酶C(二肽基肽酶I)的催化结构域本身就是一种功能完备的内蛋白酶。
Protein Expr Purif. 2019 May;157:21-27. doi: 10.1016/j.pep.2019.01.009. Epub 2019 Jan 29.
10
Therapeutic targeting of cathepsin C: from pathophysiology to treatment.靶向组织蛋白酶 C 的治疗:从病理生理学到治疗。
Pharmacol Ther. 2018 Oct;190:202-236. doi: 10.1016/j.pharmthera.2018.05.011. Epub 2018 May 26.